Literature DB >> 10655356

Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.

K Gambarotto1, M C Ploy, P Turlure, C Grélaud, C Martin, D Bordessoule, F Denis.   

Abstract

Vancomycin-resistant enterococci (VRE) have emerged as nosocomial pathogens over the last decade, but little is known about their epidemiology. We report on the prevalence of VRE fecal colonization on the basis of a prospective study among patients hospitalized in a hematology intensive care unit and among nonhospitalized subjects living in the local community. A total of 243 rectal swabs from hematology patients and 169 stool samples from the control group were inoculated onto bile-esculin agar plates with and without 6 mg of vancomycin per liter and into an enrichment bile-esculin broth supplemented with 4 mg of vancomycin per liter. A total of 37% of the hospitalized patients and 11.8% of the subjects from the community were found to be VRE carriers. A total of 65 VRE strains were isolated: 12 (18.5%) E. faecium, 46 (70.7%) E. gallinarum, and 7 (10.8%) E. casseliflavus strains. No E. faecalis strains were detected. All the E. faecium strains were of the vanA genotype. Molecular typing by pulsed-field gel electrophoresis revealed a different pattern for each vanA VRE strain that originated from an individual subject. To our knowledge, this is the first study to be carried out in a cattle-rearing region of France. It reports a higher VRE prevalence than that reported in previous European or U.S. studies. A partial explanation is the use of an enrichment broth step which enabled detection of strains which would otherwise have been missed, but the fact that subjects and patients were recruited from a predominantly agricultural area where vancomycin-related antibiotics have recently been used in animal husbandry could also contribute to the high levels of VRE in patients and subjects alike.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655356      PMCID: PMC86160     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

2.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  VanD-type glycopeptide-resistant Enterococcus faecium BM4339.

Authors:  B Perichon; P Reynolds; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Vancomycin-resistant enterococci at a large university hospital in Denmark.

Authors:  A Kjerulf; L Pallesen; H Westh
Journal:  APMIS       Date:  1996-06       Impact factor: 3.205

5.  Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital.

Authors:  J W Weinstein; M Roe; M Towns; L Sanders; J J Thorpe; G R Corey; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

6.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.

Authors:  S Handwerger; B Raucher; D Altarac; J Monka; S Marchione; K V Singh; B E Murray; J Wolff; B Walters
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

Review 7.  Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

Authors:  L C McDonald; M J Kuehnert; F C Tenover; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

8.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

9.  Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.

Authors:  J G Morris; D K Shay; J N Hebden; R J McCarter; B E Perdue; W Jarvis; J A Johnson; T C Dowling; L B Polish; R S Schwalbe
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

10.  Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.

Authors:  J Bates; J Z Jordens; D T Griffiths
Journal:  J Antimicrob Chemother       Date:  1994-10       Impact factor: 5.790

View more
  21 in total

1.  Occurrence of vancomycin-resistant enterococci in pork and poultry products from a cattle-rearing area of France.

Authors:  K Gambarotto; M C Ploy; F Dupron; M Giangiobbe; F Denis
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

2.  High prevalence of vancomycin-resistant enterococci in Swedish sewage.

Authors:  Aina Iversen; Inger Kühn; Anders Franklin; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

3.  Occurrence and relatedness of vancomycin-resistant enterococci in animals, humans, and the environment in different European regions.

Authors:  Inger Kühn; Aina Iversen; Maria Finn; Christina Greko; Lars G Burman; Anicet R Blanch; Xavier Vilanova; Albert Manero; Huw Taylor; Jonathan Caplin; Lucas Domínguez; Inmaculada A Herrero; Miguel A Moreno; Roland Möllby
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

4.  Vancomycin-resistant enterococci in Canada revisited.

Authors:  B L Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2000-05

5.  Vancomycin-resistant Enterococcus spp. isolated from wastewater and chicken feces in the United States.

Authors:  V J Harwood; M Brownell; W Perusek; J E Whitlock
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

6.  Characterization of a vancomycin-resistant Enterococcus faecalis (VREF) isolate from a dog with mastitis: further evidence of a clonal lineage of VREF in New Zealand.

Authors:  Janet M Manson; Stefanie Keis; John M B Smith; Gregory M Cook
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Convenient selective differential broth for isolation of vancomycin-resistant enterococcus from fecal material.

Authors:  Thomas J Novicki; Jeffrey M Schapiro; Bruce K Ulness; Ann Sebeste; Laurel Busse-Johnston; Kristine M Swanson; Susan R Swanzy; Wendy Leisenring; Ajit P Limaye
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Authors:  Alexander A Padiglione; Rory Wolfe; Elizabeth A Grabsch; Di Olden; Stephen Pearson; Clare Franklin; Denis Spelman; Barrie Mayall; Paul D R Johnson; M Lindsay Grayson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 9.  A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand.

Authors:  Janet M Manson; Stefanie Keis; John M B Smith; Gregory M Cook
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use.

Authors:  Janet M Manson; John M B Smith; Gregory M Cook
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.